Roivant Sciences Ltd.
ROIV
Peringkat dalam Saham
#978
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Harga Saham
$33.73
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$24.37B
Perubahan (1 hari)
-2.28%
Perubahan (1 tahun)
90.15%
Negara
GB
Perdagangan Roivant Sciences Ltd. (ROIV)
Kategori
Healthcare
Riwayat pemecahan saham untuk Roivant Sciences Ltd. (ROIV)
Saham Roivant Sciences Ltd. (simbol: ROIV) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 20, 2026.
Satu lembar saham ROIV yang dibeli sebelum Oct 20, 2026 sekarang setara dengan 0 lembar saham ROIV.
Pemecahan saham terbaru terjadi pada Oct 20, 2026.
Satu lembar saham ROIV yang dibeli sebelum Oct 20, 2026 sekarang setara dengan 0 lembar saham ROIV.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
